Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Disorder
NCT05004896Phase 2Completed
- Start
- Jul 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in bipolar disorder (BD). Started Jul 2022; status: completed.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05004896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004896.